ARTICLE | Product Development
A primer on the new coronavirus and COVID-19: BioCentury editors in conversation
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 1, 2020 12:37 AM UTC
Updated on Apr 3, 2020 at 10:06 PM UTC
The rapid pace at which COVID-19 has transformed society has rippled through the biopharma industry, affecting not only companies’ business strategies, but their product pipelines and priorities as many of them adapt on the fly to the ever-changing landscape.
In a roundtable session, Editor-in-Chief Simone Fishburn sat down to discuss issues surrounding the COVID-19 outbreak with Executive Editor Selina Koch, Washington Editor Steve Usdin, Senior Editor Lauren Martz and Associate Editor Karen Tkach Tuzman...